Overexpression of the Androgen Receptor in Human Hepatoma Cells and Its Effect on Fatty Acid Metabolism

Overview

Journal Oncol Lett

Specialty Oncology

Date 2017 Jun 11

PMID 28599448

Citations 5

Authors

Tatsuo Kanda

Xia Jiang

Masato Nakamura

Yuki Haga

Reina Sasaki

Shuang Wu

Shingo Nakamoto

Fumio Imazeki

Osamu Yokosuka

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is a predominantly male disease in which the androgen receptor (AR) serves an important pathogenic role in hepatocarcinogenesis. Fatty acid metabolism also contributes to hepatocarcinogenesis and is associated with the prognosis of cancer. The present study aimed to investigate the effects of the AR on fatty acid metabolism-associated gene expression in human hepatoma cell lines. AR-expression plasmids or control plasmids were transiently transfected into the human HCC cell lines Huh7 and HepG2. After 48 h, cellular protein and RNA were extracted and the expression of AR was confirmed by western blotting. Complementary DNA was synthesized and subjected to a quantitative polymerase chain reaction-based array to examine the expression of 84 fatty acid metabolism-associated genes. Overexpression of AR significantly downregulated the expression of 11 fatty acid metabolism-associated genes in Huh7 cells and 35 in HepG2 cells. The overexpression of AR also resulted in the upregulation of 6 fatty acid metabolism genes in HepG2 cells; however, it had no effect in Huh7 cells. Acyl-coenzyme A (CoA) thioesterase 7 and acyl-CoA oxidase 3 were downregulated in both cell lines. In conclusion, upregulation of AR via overexpression led to the disturbance of fatty acid metabolism-associated gene expression in human HCC cells. Therefore, the AR may serve a role in hepatocarcinogenesis via the regulation of hepatocellular fatty acid metabolism.

Citing Articles

The androgen receptor expression and its activity have different relationships with prognosis in hepatocellular carcinoma.

Acosta-Lopez S, Diaz-Bethencourt D, Concepcion-Massip T, Martin-Fernandez de Basoa M, Plata-Bello A, Gonzalez-Rodriguez A Sci Rep. 2020; 10(1):22046.

PMID: 33328560 PMC: 7744520. DOI: 10.1038/s41598-020-79177-2.

Anabolic androgenic steroids exert a selective remodeling of the plasma lipidome that mirrors the decrease of the de novo lipogenesis in the liver.

Balgoma D, Zelleroth S, Gronbladh A, Hallberg M, Pettersson C, Hedeland M Metabolomics. 2020; 16(1):12.

PMID: 31925559 PMC: 6954146. DOI: 10.1007/s11306-019-1632-0.

A functional genomics screen reveals a strong synergistic effect between docetaxel and the mitotic gene DLGAP5 that is mediated by the androgen receptor.

Hewit K, Sandilands E, Martinez R, James D, Leung H, Bryant D Cell Death Dis. 2018; 9(11):1069.

PMID: 30341281 PMC: 6195526. DOI: 10.1038/s41419-018-1115-7.

Development Of A Three-Gene Prognostic Signature For Hepatitis B Virus Associated Hepatocellular Carcinoma Based On Integrated Transcriptomic Analysis.

Yang Y, Lu Q, Shao X, Mo B, Nie X, Liu W J Cancer. 2018; 9(11):1989-2002.

PMID: 29896284 PMC: 5995946. DOI: 10.7150/jca.23762.

Glucose-regulated protein 78 is an antiviral against hepatitis A virus replication.

Jiang X, Kanda T, Haga Y, Sasaki R, Nakamura M, Wu S Exp Ther Med. 2017; 13(6):3305-3308.

PMID: 28587404 PMC: 5450597. DOI: 10.3892/etm.2017.4407.

References

Honeyman J, Simon E, Robine N, Chiaroni-Clarke R, Darcy D, Lim I . Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. Science. 2014; 343(6174):1010-4. PMC: 4286414. DOI: 10.1126/science.1249484. View

Meissner E, Lee Y, Osinusi A, Sims Z, Qin J, Sturdevant D . Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients. Hepatology. 2014; 61(3):790-801. PMC: 4340816. DOI: 10.1002/hep.27424. View

Nagasue N, Chang Y, Hayashi T, Galizia G, Kohno H, Nakamura T . Androgen receptor in hepatocellular carcinoma as a prognostic factor after hepatic resection. Ann Surg. 1989; 209(4):424-7. PMC: 1493974. DOI: 10.1097/00000658-198904000-00006. View

Okitsu K, Kanda T, Imazeki F, Yonemitsu Y, Ray R, Chang C . Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancer. Genes Cancer. 2011; 1(8):859-67. PMC: 3092246. DOI: 10.1177/1947601910383417. View

Kanda T, Steele R, Ray R, Ray R . Hepatitis C virus core protein augments androgen receptor-mediated signaling. J Virol. 2008; 82(22):11066-72. PMC: 2573245. DOI: 10.1128/JVI.01300-08. View

Krycer J, Brown A . Cross-talk between the androgen receptor and the liver X receptor: implications for cholesterol homeostasis. J Biol Chem. 2011; 286(23):20637-47. PMC: 3121513. DOI: 10.1074/jbc.M111.227082. View

Gehlhaus M, Schmitt N, Volk B, Meyer R . Antiepileptic drugs affect neuronal androgen signaling via a cytochrome P450-dependent pathway. J Pharmacol Exp Ther. 2007; 322(2):550-9. DOI: 10.1124/jpet.107.120303. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Zha S, Ferdinandusse S, Hicks J, Denis S, Dunn T, Wanders R . Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer. Prostate. 2004; 63(4):316-23. DOI: 10.1002/pros.20177. View

10.

Bolton E, So A, Chaivorapol C, Haqq C, Li H, Yamamoto K . Cell- and gene-specific regulation of primary target genes by the androgen receptor. Genes Dev. 2007; 21(16):2005-17. PMC: 1948856. DOI: 10.1101/gad.1564207. View

11.

Baron A, Migita T, Tang D, Loda M . Fatty acid synthase: a metabolic oncogene in prostate cancer?. J Cell Biochem. 2003; 91(1):47-53. DOI: 10.1002/jcb.10708. View

12.

Jin S, Chen J, Chen L, Histen G, Lin Z, Gross S . ALDH2(E487K) mutation increases protein turnover and promotes murine hepatocarcinogenesis. Proc Natl Acad Sci U S A. 2015; 112(29):9088-93. PMC: 4517197. DOI: 10.1073/pnas.1510757112. View

13.

Haga Y, Kanda T, Sasaki R, Nakamura M, Nakamoto S, Yokosuka O . Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis. World J Gastroenterol. 2015; 21(46):12989-95. PMC: 4674717. DOI: 10.3748/wjg.v21.i46.12989. View

14.

Koh W, Dan Y, Goh G, Jin A, Wang R, Yuan J . Dietary fatty acids and risk of hepatocellular carcinoma in the Singapore Chinese health study. Liver Int. 2015; 36(6):893-901. PMC: 4824657. DOI: 10.1111/liv.12978. View

15.

Schroder P, Segura V, Riezu J, Sangro B, Mato J, Prieto J . A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma. Funct Integr Genomics. 2011; 11(3):419-29. DOI: 10.1007/s10142-011-0230-7. View

16.

Ueda T, Bruchovsky N, Sadar M . Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J Biol Chem. 2001; 277(9):7076-85. DOI: 10.1074/jbc.M108255200. View

17.

Wu Y, Peng X, Zhu Y, Yan X, Chen W, Lin X . Hepatitis B Virus X Protein Induces Hepatic Steatosis by Enhancing the Expression of Liver Fatty Acid Binding Protein. J Virol. 2015; 90(4):1729-40. PMC: 4733992. DOI: 10.1128/JVI.02604-15. View

18.

Meyer K, Lee J, Dyck P, Cao W, Rao M, Thorgeirsson S . Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen. Carcinogenesis. 2003; 24(5):975-84. DOI: 10.1093/carcin/bgg040. View

19.

Muir K, Hazim A, He Y, Peyressatre M, Kim D, Song X . Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma. Cancer Res. 2013; 73(15):4722-31. PMC: 3855016. DOI: 10.1158/0008-5472.CAN-12-3797. View

20.

Litvinov I, Chang C, Isaacs J . Molecular characterization of the commonly used human androgen receptor expression vector, pSG5-AR. Prostate. 2004; 58(4):319-24. DOI: 10.1002/pros.20027. View